2 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 2 |
Follow Vortosiran: new trials by email Literature Review of Vortosiran trials Research Report on Vortosiran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vortosiran for VTE Prevention Vortosiran, Placebo - Venous Thromboembolism (VTE), Cancer | Phase 2 | Not yet recruiting | Ribocure Pharmaceuticals AB | 150 | 2026-10-01 | 2026-09-30 |
| Vortosiran in Atrial Fibrillation Vortosiran, Apixaban - Non-valvular Atrial Fibrillation (AF) | Phase 2 | Not yet recruiting | Ribocure Pharmaceuticals AB | 150 | 2026-10-01 | 2026-10-13 |
Atrial Fibrillation (1) · Disease (1) · Neoplasms (1) · Pulmonary Embolism (1) · Venous Thromboembolism (1)
Ribocure Pharmaceuticals AB (2)
Poland (2) · Bulgaria (1) · Denmark (1) · France (1) · Norway (1) · Romania (1) · Sweden (1)